Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF and Women Health Limited has announced an earnings conference call scheduled for Friday, May 29, 2026 at 12:00 PM IST to discuss the company's audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The call will feature key management including Dr. Manika Khanna (Chairperson & MD), Dr. Peeyush Khanna (Whole-Time Director), and Mr. Rakesh K. Sharma (CFO). Investors can join via direct registration link or dial-in numbers provided. This disclosure is made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
This is a routine investor relations announcement informing shareholders about an upcoming earnings discussion. The actual financial performance figures for Q4 and FY 2026 will be revealed during the call. No specific financial data or performance metrics are included in this intimation.